Detection of Lipopolysaccharide in Hemoglobin-Vesicles by Limulus Amebocyte Lysate Test with Kinetic-Turbidimetric Gel Clotting Analysis and Pretreatment of Surfactant

Journal of Pharmaceutical Sciences

Volumn 93, Issue 2, 2004, Pages 310-321

  Sakai, Hiromi ^a   Hisamoto, Shuji ^a   Fukutomi, Ippei ^a   Sou, Keitaro ^a   Takeoka, Shinji ^a   Tsuchida, Eishun ^a  

^a WASEDA UNIVERSITY   (Japan)

Author keywords

Calorimetry (ITC); Liposomes; Nanotechnology; Phospholipids; Surfactants

Indexed keywords

1,2 DISTEAROYLGLYCERO 3 PHOSPHATIDYLETHANOLAMINE; 1,5 BIS O HEXADECYL N SUCCINYL GLUTAMATE; AGAROSE; CHOLESTEROL; DECA(OXYETHYLENE)DODECYL ETHER; DIPALMITOYLPHOSPHATIDYLCHOLINE; ENDOTOXIN; ETHER DERIVATIVE; HEMOGLOBIN; HEMOGLOBIN VESICLE; HISTIDINE; LIPID; LIPOPOLYSACCHARIDE; LIPOSOME; MACROGOL; OXYGEN; PYRIDOXAL 5 PHOSPHATE; SURFACTANT; UNCLASSIFIED DRUG;

ACCURACY; ADSORPTION; ANALYTIC METHOD; ARTICLE; CALORIMETRY; CONCENTRATION (PARAMETERS); DILUTION; DRUG DELIVERY SYSTEM; ENCAPSULATION; GELATION; HYDROPHOBICITY; KINETIC TURBIDIMETRIC GEL CLOTTING ANALYSIS; LIMULUS LYSATE TEST; NANOTECHNOLOGY; NONHUMAN; OXYGEN TRANSPORT; PARTICLE SIZE; PHOSPHOLIPID VESICLE; QUANTITATIVE ASSAY; SOLUBILIZATION; TURBIDIMETRY;

EID: 0345241187     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10525     Document Type: Article

References (58)

1. Bangham AD. 1993. Liposomes: The Babraham connection. Chem Phys Lipids 64:275-285.
2. Lian T, Ho RJY. 2001. Trends and developments in liposome drug delivery systems. J Pharm Sci 90:667-680.
3. Djordjevich L, Mayoral J, Miller IF, Ivankovich AD. 1987. Cardiorespiratory effects of exchanging transfusions with synthetic erythrocytes in rats. Crit Care Med 15:318-323.
4. Phillips WT, Klipper RW, Awasthi VD, Rudolph AS, Cliff R, Kwasiborski V, Goins BA. 1999. Polyethylene glycol-modified liposome-encapsulated hemoglobin: nA long circulating red cell substitute. J Pharmacol Exp Ther 288:665-670.
5. Izumi Y, Sakai H, Hamada K, Takeoka S, Yamahata T, Kato R, Nishinde H, Tsuchida E, Kobayashi K. 1996. Physiologic responses to exchange transfusion with hemoglobin vesicles as an artificial oxygen carrier in anesthetized rats: Changes in mean arterial pressure and renal cortical tissue oxygen tension. Crit Care Med 24:1869-1873.
6. Sakai H, Tomiyama K, Masada Y, Takeoka S, Horinouchi H, Kobayashi K, Tsuchida E. 2003. Pretreatment of serum containing Hb-vesicles (oxygen carriers) to avoid their interference in laboratory tests. Clin Chem Lab Med 41:222-231.
7. Sakai H, Takeoka S, Wettstein R, Tsai AG, Intaglietta M, Tsuchida E. 2002. Systemic and microvascular responses to the hemorrhagic shock and resuscitation with Hb-vesicles. Am J Physiol Heart Circ Physiol 283:H1191-H1199.
8. 2 carriers determine constriction of resistance arteries and hypertension in conscious hamster model. Am J Physiol Heart Circ Physiol 279:H908-H915.
9. Goda N, Suzuki K, Naito S, Takeoka S, Tsuchida E, Ishimura Y, Tamatani T, Suematsu M. 1998. Distribution of heme oxygenase isoform in rat liver: topographic basis for carbon monoxide-mediated microvascular relaxation. J Clin Invest 101:604-612.
10. Kyokane T, Norimuzu S, Taniai H, Yamaguchi T, Takeoka S, Tsuchida E, Naito M, Nimura Y, Ishimura Y, Suematsu M. 2001. Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. Gastroenterology 120:1227-1240.
11. 2 reaction and lipid peroxidation. Bioconjugate Chem 13:1302-1308.
12. 2 carriers in a liquid state. Bioconjugate Chem 11:425-432.
13. Chang TMS. 1997. Blood substitutes: Principles, methods, products, and clinical trials. Basel: Karger.
14. Rietschel ET, Brade H. 1992. Bacterial endotoxin. Sci Am (August):54-57.
15. Fletcher JR, Ramwell PW. 1980. The effects of prostacyclin on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Circ Shock 7:299-308.
16. Shibayama Y, Asaka S, Nakata K. 1991. Endotoxin hepatotoxicity augmented by alcohol. Exp Mol Pathol 55:196-202.
17. U.S. Department of Health and Human Services Public Health Service, Food and Drug Administration. 1987. Guideline on validation of the limulus amebocyte lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices.
18. Levin J, Bang FB. 1964. The role of endotoxin in the extracellulalr coagulation of limulus blood. Bull Johns Hopkins Hospital 115:265-274.
19. Fujiwara H, Ishida S, Shimazaki Y, Naito S, Tsuchiya M, Matsuura S. 1990. Measurement of endotoxin in blood products using an endotoxin specific Limulus test reagent and its relation to pyrogenic activities in rabbit. Yakugaku Zasshi 110:332-340 (in Japanese).
20. Carr C Jr, Morrison DC. 1984. Lipopolysaccharide interaction with rabbit erythrocyte membranes. Infect Immun 43:600-606.
21. White CT, Murray AJ, Smith DJ, Greene JR, Bolin RB. 1986. Synergistic toxicity of endotoxin and hemoglobin. J Lab Clin Med 108:132-137.
22. Kaca W, Roth RI, Levin J. 1994. Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J Biol Chem 269:25078-25084.
23. Roth RI, Levin J, Chapman KW, Schmeizl M, Rickles FR. 1993. Production of modified cross-linked cell-free hemoglobin for human use: the role of quantitative determination of endotoxin contamination. Transfusion 33:919-924.
24. Yin ET, Galanos C, Kinsky S, Bradshaw RA, Wessler S, Luderitz O, Sarmiento ME. 1972. Picogram-sensitive assay for endotoxin: Gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria. Biochim Biophys Acta 261:284-289.
25. Dijkstra J, Mellors JW, Ryan JL, Szoka FC. 1987. Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J Immunol 138:2663-2670.
26. Richardson EC, Banerji B, Seid RC Jr, Levin J, Alving CR. 1983. Interactions of lipid A and liposome-associated lipid A with Limulus polyphemus amoebocytes. Infect Immun 39:1385-1391.
27. Cliff RO, Kwasiborski V, Rudolph AS. 1995. A comparative study of the accurate measurement of endotoxin in liposome encapsulated hemoglobin. Artif Cells Blood Substitutes Immobilization Biotechnol 23:331-336.
28. Harmon P, Cabral-Lilly D, Reed RA, Maurio FP, Franklin JC, Janoff A. 1997. The release and detection of endotoxin from liposomes. Anal Biochem 250:139-146.
29. Piluso LG, Martinez MY. 1999. Resolving liposomal inhibition of quantitative LAL methods. PDA J Pharm Sci Technol 53:260-263.
30. Matsumae H, Minobe S, Kindan K, Watanabe T, Sato T, Tosa T. 1990. Specific removal of endotoxin from protein solutions by immobilized histidine. Biotechnol Appl Biochem 12:129-140.
31. Minobe S, Nawata M, Watanabe T, Sato T, Tosa T. 1991. Specific assay for endotoxin using immobilized histidine and Limulus amebocyte lysate. Anal Biochem 198:292-297.
32. Minobe S, Nawata M, Shigemori N, Watanabe T. 1994. Assay of endotoxin in human plasma using immobilized histidine, Limulus amebocyte lysate and chromogenic substrate. Eur J Clin Chem Clin Biochem 32:797-803.
33. Nawata M, Minobe S, Hase M, Watanabe T, Sato T, Tosa T. 1992. Specific assay for endotoxin using immobilized histidine, Limulus amebocyte lysate and a chromogenic substrate. J Chromatogr 597:415-424.
34. Sou K, Naito Y, Endo T, Takeoka S, Tsuchida E. 2003. Effective encapsulation of proteins into size-controlled phospholipid vesicles using the freeze-thawing and extrusion. Biotechnol Progr 19:1547-1552.
35. Sakai H, Masada Y, Takekoa S, Tsuchida E. 2002. Characteristics of bovine hemoglobin for the potential source of hemoglobin-vesicles as an artificial oxygen carrier. J Biochem 131:611-617.
36. Takeoka S, Ohgushi T, Terase K, Ohmori T, Tsuchida E. 1996. Layer-controlled hemoglobin vesicles by interaction of hemoglobin with a phospholipid assembly. Langmuir 12:1755-1759.
37. Sakai H, Takeoka S, Yokohama H, Seino Y, Nishide H, Tsuchida E. 1993. Purification of concentrated hemoglobin using organic solvent and heat treatment. Protein Expr Purif 4:563-569.
38. Sou K, Endo T, Takeoka S, Tsuchida E. 2000. Polyoxyethylene-modification of the phospholipid vesicles by using the spontaneous incorporation of polyoxyethylene-lipid into the vesicles. Bioconjugate Chem 11:372-379.
39. Weiseman T, Williston S, Brandts JF, Lin LN. 1989. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal Biochem 179:131-137.
40. Aurell CA, Wistrom AO. 1998. Critical aggregation concentration of gram-negative bacterial lipopolysaccharides (LPS). Biochem Biophys Res Commun 253:119-123.
41. le Marie M, Champeil P, Moller JV. 2000. Interaction of membrane proteins and lipids with solubilizing detergents. Biochim Biophys Acta 1508:86-111.
42. Yokota M, Kambayashi J, Tanaka T, Tsujinaka T, Sakon M, Mori T. 1989. A simple turbidimetric time assay of the endotoxin in plasma. J Biochem Biophys Methods 18:97-104.
43. Oishi H, Takaoka A, Hatayama Y, Matsuo T, Sakata Y. 1985. Automated Limulus Amebocyte Lysate (LAL) test for endotoxin analysis using a new Toxinometer ET-201. J Parenteral Sci Technol 39:194-200.
44. Alving CR, Richardson EC. 1984. Mitogenic activity of lipid A and liposome-associated lipid A: Effects of epitope density. Rev Infect Disease 6:493-496.
45. Dijkstra J, Ryan JL, Szoka FC. 1988. A procedure for the efficient incorporation of wild-type lipopolysaccharide into liposomes for use in immunological studies. J Immunol Methods 114:197-205.
46. Jurgens G, Muller M, Koch MHJ, Brandenburg K. 2001. Interaction of hemoglobin with enterobacterial lipopolysaccharide and lipid A. Eur J Biochem 268:4233-4242.
47. Schmidtgen M, Brandl M. 1995. Detection of lipopolysaccharides in phospholipids and liposomes using the Limulus test. J Liposome Res 5:109-116.
48. U.S. Department of Health and Human Services Public Health Service, Food and Drug Administration. 1991. Interim guidance for human and veterinary drug products and biologicals.
49. Roth RI, Levin J. 1994. Measurement of endotoxin levels in hemoglobin preparations. Methods Enzymol 231:75-91.
50. Archambault M, Olivier M, Foiry B, Diarra MS, Paradis SE, Jacques M. 1997. Effects of pig hemoglobin binding on some physical and biological properties of Actinobacillus pleuropneumoniae lipopolysaccharides. J Endotoxin Res 4:53-65.
51. Takayama K, Mitchell DH, Din ZZ, Mukerjee P, Li C, Coleman DL. 1994. Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages. J Biol Chem 269:2241-2244.
52. Obayashi T. 1984. Addition of perchloric acid to blood samples for colorimetric Limulus test using chromogenic substrate: Comparison with conventional procedures and clinical applications. J Lab Clin Med 104:321-330.
53. de Haas CJC, van Leeuwen HJ, Verhoef J, van Kessel KPM, van Strijp JAG. 2000. Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components. J Immunol Methods 242:79-89.
54. Inada K, Endo S, Takahashi K, Suzuki M, Narita T, Yoshida T, Suda H, Komuro T, Yoshida M. 1991. Establishment of a new perchloric acid treatment method to allow determination of the total endotoxin content in human plasma by the limulus test and clinical application. Microbiol Immunol 35:303-314.
55. Yokota M, Kambayashi J, Tsujinaka T, Sakon M, Mori T, Tsuchiya M, Oishi H, Matsuura S. 1990. A new method for the quantification of β-glucan in plasma and its application in the diagnosis of postoperative infection. Jpn J Surg 20:559-566.
56. Kakinuma A, Asano T, Torii H, Sugino Y. 1981. Gelation of Limulus amoebocyte lysate by an antitumor (1 leads to 3)-β-D-glucan. Biochem Biophys Res Commun 101:434-439.
57. Tsuchiya M, Takaoka A, Tokioka N, Matsuura S. 1990. Development of an endotoxin-specific Limulus amebocyte lysate test blocking β -glucan-mediated pathway by carboxymethylated curdlan and its application. Jpn J Bacteriol 45:903-911 (in Japanese).
58. Tani T, Chang TMS, Kodama M, Tsuchiya M. 1992. Endotoxin removed from hemoglobin solution using polymixin-B immobilized fiber (PMX-B) followed by turbidimetric endotoxin assay. Biomater Artif Cells Immobilization Biotechnol 20:457-462.